Document is current

Any future updates will be listed below

New practice in semaglutide on type-2 diabetes and obesity: clinical evidence and expectation

Crossref DOI link: https://doi.org/10.1007/s11684-021-0873-2

Published Online: 2022-02-28

Published Print: 2022-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark